Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Immune to the high

Current medications used to treat drug addiction help to some extent by easing withdrawal symptoms, but these treatments cannot curb the high that people receive when they relapse and take a hit of the drug. Emma Marris explores how researchers are working on a way to make these tempting drug highs history for recovering addicts.

This is a preview of subscription content, access via your institution

Access options

Buy article

Get time limited or full article access on ReadCube.

$32.00

All prices are NET prices.

References

  1. Bonese, K.F., Wainer, B.H., Fitch, F.W., Rothberg, R.M. & Schuster, C.R. Nature 252, 708–710 (1974).

    Article  CAS  Google Scholar 

  2. Owens, S.M. & Mayersohn, M. Drug Metab. Dispos. 14, 52–58 (1986).

    CAS  PubMed  Google Scholar 

  3. Davis, R. Annu. Rev. Public Health 28, 171–194 (2007).

    Article  Google Scholar 

  4. Rigotti, N.A. N. Engl. J. Med. 346, 506–512 (2002).

    Article  Google Scholar 

  5. Laurenzana, E. J. Pharmacol. Exp. Ther. 306, 1092–1098 (2003).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Marris, E. Immune to the high. Nat Med 14, 358–361 (2008). https://doi.org/10.1038/nm0408-358

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nm0408-358

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing